Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.
Torigen Pharmaceuticals focuses on providing cancer care solutions for animals. They strive to bring novel approaches to the market to tackle companion animal cancers, building on years of existing scientific research and pushing the boundaries of innovation.The company was founded in 2013 by Ashley Kalinauskas and Mark Suckow and is based in Farmington, Connecticut, United States.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 16, 2022 | Series A | $13M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Advantage Capital | — | Series A |
Gaingels | — | Series A |